Paragraph 5 F1
A liquid formulation—
(a)
containing a botanical extract of cannabis—
(i)
with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and
(ii)
where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,
(b)
which is dispensed through a metered dose pump as a mucosal mouth spray, and
(c)
which was approved for marketing by the Medicines and Healthcare Products Regulatory Agency on 16th June 2010